| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | EVP, Ops &Strategy | Ex VP, Internal Operations +1 more
1 company
Donley Matthew Maxwell is a Chief Operating Officer at AUPH. Recent filings cover 2 purchases and 4 sales. Those positions are worth an estimated $9.7M at current prices.
Our model assigns Donley Matthew Maxwell a middling insider score of 54/100, based on 6 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -19.2%.
Donley Matthew Maxwell's largest disclosed position is in AUPH as Chief Operating Officer, worth about $9.7M. The recent filings there lean toward selling, a net 148,710 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Chief Operating Officer | Sell | 124,893 | $7.96 | $994,424.72 | -15.5% | -1.5% | +86.1% | |
| Mar 6, 2024 | AUPH Aurinia Pharmaceuticals Inc. | EVP, Ops &Strategy | Sell | 40,665 | $5.51 | $224,064.15 | -6.5% | -4.5% | +48.4% | |
| Nov 21, 2022 | AUPH Aurinia Pharmaceuticals Inc. | Ex VP, Internal Operations | Buy | 10,000 | $4.66 | $46,600.00 | +55.8% | +67.7% | +88.4% | |
| Mar 2, 2022 | AUPH Aurinia Pharmaceuticals Inc. | Ex VP, Intern'l Operations | Sell | 3,052 | $12.01 | $36,654.52 | -15.8% | -2.9% | -23.1% | |
| May 11, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Ex VP, Intern'l Operations | Buy | 9,900 | $10.07 | $99,738.54 | New | +39.7% | -14.7% |